| abstract |
The present invention relates to the use of protein kinase inhibitors, more particularly to inhibitors of protein kinase c-Jun amino-terminal kinase, JNK inhibitor sequences, chimeric peptides, or nucleic acids encoding them and pharmaceutical compositions comprising them for use in therapy Use of various diseases or conditions strongly associated with JNK signaling. |